Divakar, S K A
Ramana Reddy, M V
Cosenza, S C
Baker, S J
Perumal, D
Antonelli, A C
Brody, J
Akula, B
Parekh, S
Premkumar Reddy, E
Article History
Received: 20 March 2015
Revised: 16 June 2015
Accepted: 30 June 2015
First Online: 15 July 2015
Competing interests
: EPR is an equity holder, board member and a paid consultant of Onconova Therapeutics Inc. In addition, EPR and MVRR are named inventors on pending and issued patents filed by Temple University. MVRR is a stockholder and paid consultant of Onconova Therapeutics Inc. SCC and SJB are paid consultants of Onconova Therapeutics Inc. The other authors declare no conflict of interest.